Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease.
about
Celiac disease: prevalence, diagnosis, pathogenesis and treatmentRecent advances in coeliac diseaseIn vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tractHighly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac diseaseParallels between pathogens and gluten peptides in celiac sprueDiagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology.Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease.Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells.Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract.Prevention measures and exploratory pharmacological treatments of celiac disease.Possible drug targets for celiac disease.Randomised clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers.Investigational therapies for celiac disease.Proteomic analysis in allergy and intolerance to wheat products.Pharmacotherapy and management strategies for coeliac disease.Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management.In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.Current status of drugs in development for celiac disease.Prolyl-specific peptidases for applications in food protein hydrolysis.Extensive in vitro gastrointestinal digestion markedly reduces the immune-toxicity of Triticum monococcum wheat: implication for celiac disease.Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients.Microbial Proteases in Baked Goods: Modification of Gluten and Effects on Immunogenicity and Product Quality.Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.Oral proteases: a new approach to managing coeliac disease.Elevated CD8 T cell responses in type 1 diabetes patients to a 13 amino acid coeliac-active peptide from α-gliadin.Enzymatic detoxification of gluten by germinating wheat proteases: implications for new treatment of celiac disease.Significant Hydrolysis of Wheat Gliadin by Bacillus tequilensis (10bT/HQ223107): a Pilot Study.In vitro digestive stability of complexes between gliadin and synthetic blocking peptidesA Grounded Guide to Gluten: How Modern Genotypes and Processing Impact Wheat Sensitivity
P2860
Q22305490-5F4A33E6-9F45-4650-A31F-E31057531514Q22306523-7FFD10DA-79AD-4F20-A43B-BFEAAFC4CABAQ24627253-356125C8-6F49-4494-A204-8EE231D9D643Q28239734-6F02CA32-983A-44C2-9CCC-F48CB70E2449Q33329537-02760B32-ACA8-4C12-AE36-C6FBF8CDEFE7Q33956436-AE1B1055-3AA7-47C1-8132-AA1106704125Q34009143-2D2D7161-1E7D-4A04-A00D-310BC1736E48Q34022801-4809CA97-442D-40E8-9927-459B3D0E077CQ34034638-02F18247-F7D8-4A2C-BD0D-1902E8E6E6D0Q34623902-A85A20EB-D868-4E9F-AC6F-81059EBCD396Q36539486-3717B05A-C24B-434F-AFCF-2EF186907A8AQ37275552-703699B6-8B40-4AC8-A125-4891E4372422Q37638684-2F2808D6-1698-4BE9-BD6E-B0AB50FDD2D8Q37844154-6114B443-B41F-493B-A9A4-013A90C93B9EQ37896092-8ED5B5F4-84AA-4B75-BD64-9379ABF2F446Q37965669-10C7A06C-4193-4686-8D05-7ED8C9468319Q37979161-E90E4B93-25C4-4094-83C5-927B9DD121A7Q38016781-579F1A88-6EFA-47C8-B4D2-D6B3B4630989Q38021639-D46FD354-6CF4-40A2-BEBA-242BD249A23CQ38210088-891D969C-9025-4A01-AC72-D9515BE00EAAQ38560146-B0B09AA0-0C34-4DA9-86D0-686175EE7ABFQ38870421-9F46A294-A183-4065-8A48-E763498AF687Q39021180-D9006586-AE6E-49AC-BD77-3063376B7405Q39148065-D822CE76-81C6-4316-A316-67D9E9DD0EC1Q39883644-213D5861-A4F9-40EB-B782-49385205DA88Q42061479-6BE6E10D-B7FC-4C27-8CB3-DB312102DA94Q44988335-703A7914-53CC-451F-BF9E-3BB5970B585FQ46057460-25B524C7-CFB3-4C04-854E-CCA615FD2C56Q47743038-2A26AFB3-D1B2-4F7F-8169-73027A11A611Q56892820-DC4B3E93-4462-48AE-BC4D-D70F7A5D92ECQ57534899-5B49E2C0-8B60-438C-8211-A3B108EAE777
P2860
Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Limited efficiency of prolyl-e ...... in peptides in celiac disease.
@ast
Limited efficiency of prolyl-e ...... in peptides in celiac disease.
@en
Limited efficiency of prolyl-e ...... in peptides in celiac disease.
@nl
type
label
Limited efficiency of prolyl-e ...... in peptides in celiac disease.
@ast
Limited efficiency of prolyl-e ...... in peptides in celiac disease.
@en
Limited efficiency of prolyl-e ...... in peptides in celiac disease.
@nl
prefLabel
Limited efficiency of prolyl-e ...... in peptides in celiac disease.
@ast
Limited efficiency of prolyl-e ...... in peptides in celiac disease.
@en
Limited efficiency of prolyl-e ...... in peptides in celiac disease.
@nl
P2093
P50
P1433
P1476
Limited efficiency of prolyl-e ...... in peptides in celiac disease.
@en
P2093
Celine Candalh
Christophe Cellier
Christophe Dugave
Martine Heyman
Teresita Vidal-Martinez
P304
P356
10.1053/J.GASTRO.2005.06.016
P407
P577
2005-09-01T00:00:00Z